MYOCARDIAL INFARCTION IN THE PRE- AND POST-COVID-19 ERA: A REVIEW OF EMERGING PATHOPHYSIOLOGICAL CHANGES

Heart attack (myocardial infarction) takes place when blood flow to the heart is completely or partially blocked(obstructed). Results in necrosis of heart cells and ischemia. The major risk factors for heart attack PRE COVID-19 pandemic including modifiable factors such as hypertension, hyperlipidemia, smoking, diabetes mellitus, obesity, sedentary lifestyle along with non-modifiable factors are age, sex, genetic transfer. Condition such as smoking, hypertension and diabetes mellitus that majorly increase the risk of coronary heart disease and subsequent myocardial infarction. After COVID-19 it is evident that infection will directly or indirectly affects cardiovascular health. This SARS-CoV2 infects heart muscle cells through ACE2 (angiotensin converting enzyme 2) receptors leading to direct effect on myocardial damage, microvascular thrombosis and endothelial dysfunction. Both PRE-COVID and POST-COVID heart attacks (myocardial infarction) has similar ischemic mechanisms but different in triggering the vascular damage and extent of inflammation. For better understanding the long term heart related diseases continued research is necessary.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-04-01
DOI
https://doi.org/10.5281/zenodo.19330244
Primary Topic
COVID-19 Clinical Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

MYOCARDIAL INFARCTION IN THE PRE- AND POST-COVID-19 ERA: A REVIEW OF EMERGING PATHOPHYSIOLOGICAL CHANGES

Udaya Guttikonda*1, V. Srisai2, Damavarapu Archana3, Kandukuru Aasritha Varshini4, Pachipulusu Harshini5, Bacchu Sumana6
Zenodo (CERN European Organization for Nuclear Research)
COVID-19 Clinical Research Studies
article

MYOCARDIAL INFARCTION IN THE PRE- AND POST-COVID-19 ERA: A REVIEW OF EMERGING PATHOPHYSIOLOGICAL CHANGES

Udaya Guttikonda*1, V. Srisai2, Damavarapu Archana3, Kandukuru Aasritha Varshini4, Pachipulusu Harshini5, Bacchu Sumana6
article en

Abstract

Heart attack (myocardial infarction) takes place when blood flow to the heart is completely or partially blocked(obstructed). Results in necrosis of heart cells and ischemia. The major risk factors for heart attack PRE COVID-19 pandemic including modifiable factors such as hypertension, hyperlipidemia, smoking, diabetes mellitus, obesity, sedentary lifestyle along with non-modifiable factors are age, sex, genetic transfer. Condition such as smoking, hypertension and diabetes mellitus that majorly increase the risk of coronary heart disease and subsequent myocardial infarction. After COVID-19 it is evident that infection will directly or indirectly affects cardiovascular health. This SARS-CoV2 infects heart muscle cells through ACE2 (angiotensin converting enzyme 2) receptors leading to direct effect on myocardial damage, microvascular thrombosis and endothelial dysfunction. Both PRE-COVID and POST-COVID heart attacks (myocardial infarction) has similar ischemic mechanisms but different in triggering the vascular damage and extent of inflammation. For better understanding the long term heart related diseases continued research is necessary.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 8%
COVID-19 Clinical Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

MYOCARDIAL INFARCTION IN THE PRE- AND POST-COVID-19 ERA: A REVIEW OF EMERGING PATHOPHYSIOLOGICAL CHANGES — Udaya Guttikonda*1, V. Srisai2, Damavarapu Archana3, Kandukuru Aasritha Varshini4, Pachipulusu Harshini5, Bacchu Sumana6 · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS